+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
CSL Behring - logo

CSL Behring is a global leader in the plasma protein biotherapeutics industry. It specializes in bleeding disorder, fluid replacement, hereditary angioedema, immunoglobulin, pulmonary, and wound healing biotherapies. Its therapies are being used to treat coagulation disorders, primary immune deficiencies, neurological conditions, inherited respiratory diseases and a variety of others. The company was founded in 2000 and is based in King of Prussia, Pennsylvania.

From
Idiopathic Pulmonary Fibrosis - Pipeline Insight, 2024 - Product Thumbnail Image

Idiopathic Pulmonary Fibrosis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 250 Pages
  • Global
From
From
Leukocyte Adhesion Deficiency Management Global Market Report 2024 - Product Thumbnail Image

Leukocyte Adhesion Deficiency Management Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Thrombophilia Global Market Report 2024 - Product Thumbnail Image

Thrombophilia Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
Bleeding Disorders Treatment Global Market Report 2024 - Product Thumbnail Image

Bleeding Disorders Treatment Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Biobetters Market - Growth, Trends, and Forecast(2022 - 2027) - Product Thumbnail Image

Biobetters Market - Growth, Trends, and Forecast(2022 - 2027)

  • Report
  • January 2022
  • 115 Pages
  • Global
From
Nephrology Drugs Global Market Report 2024 - Product Thumbnail Image

Nephrology Drugs Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
From
Albumin Excipient Global Market Report 2024 - Product Thumbnail Image

Albumin Excipient Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Loading Indicator